OptimizeRx Corporation OPRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.50M | 19.84M | 32.24M | 26.07M | 29.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.50M | 19.84M | 32.24M | 26.07M | 29.20M |
| Cost of Revenue | 4.82M | 4.91M | 8.14M | 8.55M | 10.56M |
| Gross Profit | 15.69M | 14.93M | 24.10M | 17.52M | 18.64M |
| SG&A Expenses | 11.44M | 10.07M | 14.09M | 14.39M | 11.26M |
| Depreciation & Amortization | 1.06M | 1.06M | 1.08M | 1.08M | 1.07M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.59M | 19.45M | 23.30M | 24.02M | 25.99M |
| Operating Income | -88.00K | 396.00K | 8.94M | 2.05M | 3.21M |
| Income Before Tax | -1.10M | -644.00K | 7.47M | 1.05M | 1.73M |
| Income Tax Expenses | -393.00K | -149.00K | 2.45M | 270.00K | 199.00K |
| Earnings from Continuing Operations | -703.00K | -495.00K | 5.02M | 779.00K | 1.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -703.00K | -495.00K | 5.02M | 779.00K | 1.53M |
| EBIT | -88.00K | 396.00K | 8.94M | 2.05M | 3.21M |
| EBITDA | 914.00K | 1.40M | 10.44M | 2.99M | 4.22M |
| EPS Basic | -0.04 | -0.03 | 0.27 | 0.04 | 0.08 |
| Normalized Basic EPS | -0.04 | -0.02 | 0.26 | 0.04 | 0.06 |
| EPS Diluted | -0.04 | -0.03 | 0.25 | 0.04 | 0.08 |
| Normalized Diluted EPS | -0.04 | -0.02 | 0.25 | 0.03 | 0.06 |
| Average Basic Shares Outstanding | 18.79M | 18.76M | 18.66M | 18.58M | 18.51M |
| Average Diluted Shares Outstanding | 18.79M | 18.76M | 19.38M | 19.46M | 19.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |